Tiny study compares migraine drug delivery methods
NCT ID NCT06074016
First seen May 06, 2026 · Last updated May 06, 2026
Summary
This early-phase study looked at how the migraine medication zolmitriptan behaves in the body when taken as a pill versus a nasal spray. Eight healthy volunteers took both forms, and researchers measured drug levels and vital signs over 24 hours. The goal was to understand the differences in absorption and effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IMIM (Hospital del Mar Medical Research Institute)
Barcelona, 08003, Spain
Conditions
Explore the condition pages connected to this study.